RAC 1.86% $1.64 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-62

  1. 2,630 Posts.
    lightbulb Created with Sketch. 10068
    I think you have confused IND with NDA.

    One thing that I should add is that PRVs can be very valuable in collaborative partnerships - imagine just for example that RAC and a partner work together to fund a trial with the partner contributing the cash and Race RC220 and the RPDD. This can be a very cost effective way of funding additional trials that otherwise could not be afforded.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.64
Change
0.030(1.86%)
Mkt cap ! $281.0M
Open High Low Value Volume
$1.60 $1.65 $1.59 $41.72K 26.04K

Buyers (Bids)

No. Vol. Price($)
1 484 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.64 411 1
View Market Depth
Last trade - 11.06am 05/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.